Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Foodconsumer & Others


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards


Diet & Health : Cancer Last Updated: May 5, 2009 - 12:58:27 PM


Broccoli and soy may help prevent breast cancer from spreading
By Ben Wasserman
Apr 16, 2007 - 12:53:26 PM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   
3,3-Diindolylmethane and genistein found in broccoli and soy respectively may help prevent the spreading of breast cancer and ovarian cancer, according to a study by researchers at the University of California, Los Angeles.

Studies have linked eating such foods as broccoli and soy to reduced risk for some types of cancer, but it is not well understood how these foods could possibly provide such protection against cancer.

In the study, researchers discovered a biological mechanism which explains that diindolylmethane (DIM), a compound resulting from digestion of cruciferous vegetables, and genistein, a major isoflavone in soy prevent the spread of cancer by reducing production of two proteins whose chemotactic attraction to each other is necessary for the spread of breast and ovarian cancers.

When applied to motile cancer cells, purified DIM and genistein significantly reduced cell migration and invasion, according to the study, which was presented at the 2007 Annual Meeting of the American Association for Cancer Research.

"We think these compounds might slow or prevent the metastasis of breast and ovarian cancer, which would greatly increase the effectiveness of current treatments," said Erin Hsu, a graduate student in molecular toxicology. "But we need to test that notion in animals before we can be more definitive."

Both DIM and genistein are being developed for use as a preventive and a chemotherapy treatment for breast cancer, but more extensive toxicological studies are needed, the researchers said.

Purified genistein, a phytochemical that is similar to estrogen, is toxic to organs like ovaries and at high level, it can make mice infertile or subfertile, according to a government study, which was conducted by W Jefferson, E Padilla-Banks, R Newbold and M Pepling ad published in the January 2006 issue of Biology of Reproduction.

In the current study, the researchers examined the effect of DIM and genistein on the "CXCR4/CXCL12 axis," which is known to play a central role in the spreading of breast cancer and the development of ovarian cancer.

CXCR4 chemokine receptors are produced by primary cancer cells on their surface while CXCL 12 chemkine ligands are produced by the organs to which the cancer cells may spread to.    The attraction between the two stimulates the invasive properties of cancer cells and draws the cancer cells to the organs.

Purified DIM or genistein when applied to breast and ovarian cancer cell lines reduced levels of CXCR4 and CXCL12 messenger RNAs and proteins in a dose-dependent manner, according to Hsu.

In the study, the researchers placed the cells in one end of a compartment and watched how they moved toward CXCL12 at the other end with and without DIM or genistein applied.

"The cells degrade the extracellular matrix in the upper compartment in order to move toward CXCL12 in the lower compartment, a system that represents a cell culture model for invasiveness," she said.

However, when the cells were treated with either DIM or genistein, movement toward CXCL12 was reduced by at least 80 percent compared to untreated cells, the researchers said.

The same chemotactic attraction is thought to be the way for more than 23 types of cancer to develop, Hsu said.   The researchers have found that DIM and genistein substantially reduced messenger RNA expression of CXCR4 and CXCL 12 when they were applied to melanoma and prostate cancer cells.

"We have also tested other phytochemicals and seen similar effects, indicating that this mechanism may mediate protective effects of other vegetable products as well," Hsu said.

The researchers said the amount of DIM and genistein used in this study is probably comparable to a high dose of supplements, which can't be achieved through consumption of food alone.






© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites












We have moved to Food Consumer . Org



disclaimer | advertising | jobs | privacy | about us | newsletter | Submit news/articles
link partners: | Buy Viagra | MarketAmerica.com |
Buy a home | Auto Insurance | Mortgage refinancing | DaytonaCPA.com | Take Your Blog to a Higher Level
© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.